This website uses cookies to help us understand the way visitors use our website. We can't identify you with them and we don't share the data with anyone else. If you click Reject we will set a single cookie to remember your preference. Find out more in our privacy policy.

Impact stories

Whole genome sequencing to identify transmission clusters and variants of concern

The COVID-19 Genomics UK Consortium conducted large-scale, rapid whole-genome sequencing of SARS-CoV-2, the virus causing COVID-19. The data generated provided critical information on transmission clusters occurring in the workplace, pubs, clubs and schools. The work is estimated to have saved thousands of lives.
Using rapid viral sequencing to understand COVID-19 transmission in hospitals

Rapid viral sequencing information was provided to infection, prevention and control teams in hospitals to discover whether this would allow them to implement control measures more accurately and faster to reduce spread of COVID. The results from this study will be critical to planning what is needed to harness genomic data linked to patient data for controlling hospital outbreaks and managing individual patients.
Uniting clinical and academic leaders across London to evaluate changes in care

The London Evaluation Cell, established in June 2020, has led to the development of a network that enables collaboration and knowledge sharing that did not previously exist. This enables clinical and academic health leaders to collectively identify and set evaluation priorities, with the aim of rapidly translating knowledge into service provision across the regional care sector.
Providing enhanced remote monitoring for COVID-19 patients

Through our Patient Safety Collaborative we supported the use of pulse oximeters in our local health and care system, to enable COVID patients to safely monitor their condition from home.
Proactive care frameworks transform care for patients with long-term conditions during COVID-19

UCLPartners team developed a series of long-term condition frameworks (for type 2 diabetes, hypertension, COPD, asthma, atrial fibrillation and lipids) that have supported primary care teams to transform the way they deliver proactive care for patients.
Enhancing patient safety with innovative technology

Essex Partnership University NHS Foundation Trust have partnered with Oxehealth to improve the safety, quality and efficiency of care on their inpatient mental health wards and have reported the first insights from the evaluation. We are working with Oxehealth on a larger scale real world validation of the Oxevision platform at EPUT and supporting the technology’s adoption at other NHS Trusts.
Cladribine – an innovative treatment for adults with highly active relapsing remitting MS

Clinical trials conducted by UCLPartners' AHSC from 2010-2015 showed that Cladribine is an effective oral treatment for highly active MS. Since then, UCLPartners has been driving the spread and adoption of the drug in clinical practice.
Increasing use of the COPD Discharge Bundle in acute trusts

The British Thoracic Society (BTS) has developed a Chronic Obstructive Pulmonary Disease (COPD) discharge care bundle that aims to improve care, help patients manage their condition at home, and reduce readmissions. As one of 15 patient safety collaboratives in England, UCLPartners has supported nine trusts to adopt the care bundle for patients admitted to hospital with COPD.
London AHSNs work together to embed virtual consultations across the capital

Three London Academic Health Science Networks (AHSNs) worked together to support Trusts in the region to quickly embed virtual consultations to safeguard patients and staff during the pandemic.
Understanding the impact of training to identify and refer women affected by domestic violence and abuse

Identification and Referral to Improve Safety (IRIS) is a primary-care-delivered, evidence-based intervention to improve the health, safety and experience of women affected by domestic violence and abuse.